FI915649A0 - Cystein tiol-skyddade peptider foer anvaendning vid immunologiska bestaemningar. - Google Patents
Cystein tiol-skyddade peptider foer anvaendning vid immunologiska bestaemningar.Info
- Publication number
- FI915649A0 FI915649A0 FI915649A FI915649A FI915649A0 FI 915649 A0 FI915649 A0 FI 915649A0 FI 915649 A FI915649 A FI 915649A FI 915649 A FI915649 A FI 915649A FI 915649 A0 FI915649 A0 FI 915649A0
- Authority
- FI
- Finland
- Prior art keywords
- skyddade
- immunologiska
- bestaemningar
- peptider
- tiol
- Prior art date
Links
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 235000018102 proteins Nutrition 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241001430294 unidentified retrovirus Species 0.000 abstract 2
- DJQYYYCQOZMCRC-UHFFFAOYSA-N 2-aminopropane-1,3-dithiol Chemical group SCC(N)CS DJQYYYCQOZMCRC-UHFFFAOYSA-N 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 abstract 1
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 abstract 1
- 241000714259 Human T-lymphotropic virus 2 Species 0.000 abstract 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36051389A | 1989-06-02 | 1989-06-02 | |
| US36051389 | 1989-06-02 | ||
| US9003148 | 1990-06-04 | ||
| PCT/US1990/003148 WO1990015071A1 (en) | 1989-06-02 | 1990-06-04 | Cysteine thiol-protected peptides for use in immunoassays |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI915649A0 true FI915649A0 (fi) | 1991-11-29 |
| FI102834B1 FI102834B1 (fi) | 1999-02-26 |
| FI102834B FI102834B (fi) | 1999-02-26 |
Family
ID=23418295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI915649A FI102834B (fi) | 1989-06-02 | 1991-11-29 | Kysteiinitioli-suojatut peptidit käytettäviksi immunologisissa määrity ksissä |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0474789B1 (fi) |
| JP (1) | JP3404035B2 (fi) |
| KR (1) | KR960013600B1 (fi) |
| AT (1) | ATE162799T1 (fi) |
| AU (1) | AU652919B2 (fi) |
| CA (1) | CA2056381C (fi) |
| DE (1) | DE69032009T2 (fi) |
| DK (1) | DK0474789T3 (fi) |
| ES (1) | ES2113860T3 (fi) |
| FI (1) | FI102834B (fi) |
| NO (1) | NO304151B1 (fi) |
| WO (1) | WO1990015071A1 (fi) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083504A (en) * | 1989-08-24 | 2000-07-04 | Bioclonetics Incorporated | Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) |
| US5459060A (en) * | 1989-08-24 | 1995-10-17 | Bioclonetics Incorporated | Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) |
| US6008044A (en) * | 1989-08-24 | 1999-12-28 | Bioclonetics | Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC) |
| EP0438332B1 (fr) * | 1990-01-16 | 1998-04-08 | Orgenics Ltd. | Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA |
| JP2003513022A (ja) * | 1999-10-27 | 2003-04-08 | インノジェネティクス・エヌ・ブイ | 天然に似たコンフォメーションを有する酸化還元の可逆的なｈｃｖタンパク質 |
| JP5182069B2 (ja) * | 2008-12-24 | 2013-04-10 | Ｊｎｃ株式会社 | チオール基を有する刺激応答性磁性微粒子及びその利用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4111924A (en) * | 1976-01-05 | 1978-09-05 | Takeda Chemical Industries, Ltd. | Method for removal of thiol-protecting groups |
| FR2525592B1 (fi) * | 1982-04-26 | 1984-09-14 | Pasteur Institut | |
| US4689398A (en) * | 1984-06-20 | 1987-08-25 | Ortho Diagnostic Systems Inc. | HTLV test using synthetic peptides |
| DE3788397T3 (de) * | 1986-03-24 | 2003-11-27 | Ortho Pharma Corp | Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung. |
| EP0247557B1 (en) * | 1986-05-27 | 1994-04-20 | F. Hoffmann-La Roche Ag | HTLV-III(LAV) Envelope peptides |
| GB8828097D0 (en) * | 1988-12-01 | 1989-01-05 | Wellcome Found | Peptides |
-
1990
- 1990-06-04 AT AT90911054T patent/ATE162799T1/de not_active IP Right Cessation
- 1990-06-04 JP JP51045090A patent/JP3404035B2/ja not_active Expired - Lifetime
- 1990-06-04 AU AU60532/90A patent/AU652919B2/en not_active Expired
- 1990-06-04 EP EP90911054A patent/EP0474789B1/en not_active Expired - Lifetime
- 1990-06-04 KR KR1019910701744A patent/KR960013600B1/ko not_active IP Right Cessation
- 1990-06-04 DK DK90911054T patent/DK0474789T3/da active
- 1990-06-04 WO PCT/US1990/003148 patent/WO1990015071A1/en active IP Right Grant
- 1990-06-04 DE DE69032009T patent/DE69032009T2/de not_active Expired - Fee Related
- 1990-06-04 CA CA002056381A patent/CA2056381C/en not_active Expired - Lifetime
- 1990-06-04 ES ES90911054T patent/ES2113860T3/es not_active Expired - Lifetime
-
1991
- 1991-11-29 FI FI915649A patent/FI102834B/fi active
- 1991-11-29 NO NO914725A patent/NO304151B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR960013600B1 (ko) | 1996-10-09 |
| NO914725L (no) | 1992-01-29 |
| CA2056381A1 (en) | 1990-12-03 |
| DK0474789T3 (da) | 1998-09-28 |
| NO304151B1 (no) | 1998-11-02 |
| JPH04505623A (ja) | 1992-10-01 |
| ES2113860T3 (es) | 1998-05-16 |
| FI102834B1 (fi) | 1999-02-26 |
| WO1990015071A1 (en) | 1990-12-13 |
| FI102834B (fi) | 1999-02-26 |
| AU6053290A (en) | 1991-01-07 |
| EP0474789B1 (en) | 1998-01-28 |
| EP0474789A1 (en) | 1992-03-18 |
| EP0474789A4 (en) | 1992-06-03 |
| ATE162799T1 (de) | 1998-02-15 |
| AU652919B2 (en) | 1994-09-15 |
| DE69032009D1 (de) | 1998-03-05 |
| KR920701236A (ko) | 1992-08-11 |
| CA2056381C (en) | 2000-08-22 |
| NO914725D0 (no) | 1991-11-29 |
| DE69032009T2 (de) | 1998-07-23 |
| JP3404035B2 (ja) | 2003-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI870447A0 (fi) | Htlv-iii-hoeljepeptider. | |
| PT90574A (pt) | Processo de preparacao de polipeptidos e de determinacao da presenca de anticorpos de proteina latente anti-virus do papiloma | |
| DK614987A (da) | Syntetiske htlv-iii peptider, praeparater og anvendelser deraf | |
| EA200100943A1 (ru) | Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител | |
| BR9106220A (pt) | Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c. | |
| FI902143A0 (fi) | Hiv-peptider, artificiella hiv -antigener och immunobestaemningsfoerpackningar. | |
| FI915649A0 (fi) | Cystein tiol-skyddade peptider foer anvaendning vid immunologiska bestaemningar. | |
| ES2080047T3 (es) | Peptidos hiv y metodos para la deteccion de hiv. | |
| DE69015708D1 (de) | Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1. | |
| NO904292L (no) | Fremgangsmaate for fremstilling av antikoagulerende peptider. | |
| DE69011122D1 (de) | Rubella-e1 und c peptide. | |
| ES2074591T3 (es) | Expresion de polipeptidos de vih 1 y 2 y su utilizacion. | |
| NO894880L (no) | Fremgangsmaate for fremstilling av antikoagulerende peptider. | |
| GR900100608A (el) | Κυστέϊνο ?ειολο-προστατευμένα πεπτίδια γιά χρήση σε ανοσοδοκιμασίες. | |
| DE69017352D1 (de) | An HIV relatierte Peptide. | |
| DE69012989D1 (de) | Peptiden von retinblastoma gen produkten und antikoerper dagegen. | |
| Blake et al. | Cysteine thiol-protected peptides for use in immunoassays | |
| DE69921589D1 (de) | Peptide zum Nachweis von HIV-1-Guppe O | |
| PT90800A (pt) | Processo para a preparacao de antigenios precursores das glicoproteinas de involucro de um retrovirus humano hiv-2 e de antigenios que apresentem uma analogia imonulogiga com estes ultimos e sua aplicacao ao diagnostico | |
| DK369888A (da) | Peptidforbindelser | |
| FI883765A (fi) | Antikroppar mot biologiskt aktiva polypeptider och deras anvaendning vid diagnostiska foerfaranden. |